Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD Aug 30, 2007
Opko Health, Inc. Announces Early Termination of Hart-Scott-Rodino Waiting Period for Proposed Purchase of Shares by Dr. Phillip Frost Jul 12, 2007
